In chest pain management, which statement best describes aspirin's pharmacologic action?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the NREMT EMT Test with group sessions. Access flashcards and multiple-choice questions. Enhance readiness for your exam through collaborative practice!

Multiple Choice

In chest pain management, which statement best describes aspirin's pharmacologic action?

Explanation:
In chest pain management, aspirin’s primary pharmacologic action is its antiplatelet effect. It irreversibly inhibits COX-1 in platelets, which reduces thromboxane A2 production and prevents platelet aggregation. Because platelets can’t make new COX-1, this effect lasts for the platelets’ lifespan (roughly 7–10 days) until new platelets are formed. That antiplatelet action helps limit clot growth and may reduce the risk of progression to a heart attack in suspected acute coronary syndrome. While aspirin is an NSAID with analgesic and anti-inflammatory properties, those effects are not the key reason it’s used in this scenario.

In chest pain management, aspirin’s primary pharmacologic action is its antiplatelet effect. It irreversibly inhibits COX-1 in platelets, which reduces thromboxane A2 production and prevents platelet aggregation. Because platelets can’t make new COX-1, this effect lasts for the platelets’ lifespan (roughly 7–10 days) until new platelets are formed. That antiplatelet action helps limit clot growth and may reduce the risk of progression to a heart attack in suspected acute coronary syndrome. While aspirin is an NSAID with analgesic and anti-inflammatory properties, those effects are not the key reason it’s used in this scenario.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy